Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020646 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nivedita Patni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Lipodystrophy, Familial Partial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Autosomal recessive familial partial lipodystrophy type 5 (FPLD5) due to a homozygous NP_001186481.1; p.E186* CIDEC variant has previously been reported in a 19-year-old female with diabetes mellitus, hypertriglyceridemia, and hepatic steatosis. Now, we report an 18-year-old Hispanic female who presented with FPL, along with hirsutism, acanthosis nigricans, and marked insulin resistance, and was found to have an extremely rare homozygous variant in CIDEC (NM_001199623.2:c.224G>T; NP_001186552.1; p.Ser75Ile) by whole exome sequencing. She also harbored a novel homozygous variant in WRN (NM_000553.4:c.1856T>G; NP_000544; p.Leu619Arg). Both serine 75 of the CIDEC protein and leucine 619 of the WRN protein were well conserved across species. She developed an invasive papillary thyroid carcinoma at the age of 17 years. Our report confirms the previously reported association of the biallelic CIDEC variant with the FPL phenotype and also highlights the extremely rare possibility of co-occurrence of FPLD5 with thyroid cancer, a clinical feature of Werner syndrome. Thus, our patient may not only need surveillance for the metabolic complications of FPLD5, such as diabetes, hypertriglyceridemia, and hepatic steatosis, but also for WRN-associated neoplasms and features of premature aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- O'Donnell School of Public Health, UT Southwestern Medical Center, Dallas, TX 75390, USA.
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- The Section of Nutrition and Metabolic Diseases, Division of Endocrinology, Department of Internal Medicine and the Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Nivedita Patni, Chao Xing, Rebecca J Brown
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Patni, N., Xing, C., Huang, C. Y., Brown, R. J., & Garg, A. (2026). Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020646
Vancouver
Patni N, Xing C, Huang CY, Brown RJ, Garg A. Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020646
BibTeX
@article{Patni2026,
author = {Patni, Nivedita and Xing, Chao and Huang, Chun-Yuan and Brown, Rebecca J and Garg, Abhimanyu},
title = {Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020646}
}
EUVIMED